Cerenis Therapeutics Holding Stock price Euronext Paris
Equities
FR0012616852
Biotechnology & Medical Research
Sales 2023 | 4.6M 4.97M | Sales 2024 * | 4.6M 4.97M | Capitalization | 29.95M 32.39M |
---|---|---|---|---|---|
Net income 2023 | -3M -3.24M | Net income 2024 * | -6M -6.49M | EV / Sales 2023 | 9.02 x |
Net cash position 2023 * | 100K 108K | Net cash position 2024 * | 3.4M 3.68M | EV / Sales 2024 * | 5.77 x |
P/E ratio 2023 * |
-6.64
x | P/E ratio 2024 * |
-6.2
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 77.63% |
Managers | Title | Age | Since |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Director of Finance/CFO | - | 08-04-30 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 15-02-05 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.19% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |